top of page
Catalyst Clinical Research
Active
Catalyst is an oncology-focused Contract Research Organization (“CRO”) providing resources and conducting clinical trials for biotech and pharma companies
How We Partnered
Situation:
Two primary LPs in NQPE Fund I wished to realize an attractive return of 2.8x; Apogem initiated a proprietary process to recapitalize the business into a continuation vehicle
Structure:
Single-asset CV with 5 year term and dry powder to support M&A.
Headquarters:
Wilmington, NC
Stage:
Active
Business Model:
Recurring Services
Sponsor:
QHP Capital
Investment Date:
October 2022
Investment Thesis
Stable business with multi-year contracts
Strong growth and high revenue visibility
Attractive industry, serving high-growth oncology end markets
Book-to-bill ratio exceeding industry average
Strong GP alignment
bottom of page